Transcenta Therapeutics
Organization
Trials
Phase 2, Not yet recruiting, 110 people, Sep 8, 2026
Phase 3, Not yet recruiting, 820 people, Oct 23, 2023
Phase 1/2, Active, not recruiting, 320 people, Jul 31, 2020
Phase 1/2, Active, not recruiting, 150 people, May 21, 2020